Background illustration for clinical trials search

Paid Clinical Trials Plainfield

Discover 2,367 paid clinical trials in Plainfield, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer

for
Colorectal Cancer, Early Onset Colorectal Cancer, Diet Habit,
Location: Chicago IL, Denver CO
Sponsor: San Raffaele University

Sex: All

Age: 18 - 49

Code: NCT05732623

Recruiting

Prostate Cancer Treatment Using Androgen Deprivation Therapy and Focal Prostate Ablation

for
Prostate Cancer
Location: Chicago IL
Sponsor: University of Chicago

Sex: Male

Age: 18+

Code: NCT05790213

Phase2, Recruiting

Study of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma

for
Multiple Myeloma, Relapse Multiple Myeloma
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT05789303

Phase2, Recruiting

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

for
Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma,
Location: Chicago IL, New Berlin WI, Saint Joseph MI,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05633615

Phase2, Recruiting

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

for
Low Grade Astrocytoma, Low Grade Glioma,
Location: Chicago IL, Peoria IL, Milwaukee WI, Madison WI,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 2 - 21

Code: NCT04166409

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Hypofractionation (Radiation) Trial for Multiple Myeloma

for
Multiple Myeloma
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT06270888

Phase1, Recruiting

A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia

for
B Acute Lymphoblastic Leukemia Associated With Down Syndrome,
Location: Chicago IL, Milwaukee WI, Madison WI, Kalamazoo MI,
Sponsor: Children's Oncology Group

Sex: All

Age: 6 - 39

Code: NCT05702645

Recruiting

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

for
Stage II Nasopharyngeal Carcinoma AJCC v8,
Location: Chicago IL, Milwaukee WI, Grand Rapids MI,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 21

Code: NCT06064097

Phase2, Recruiting

Study of Nutrition and Exercise in Adults Hospitalized for Treatment of Acute Lymphoblastic Leukemia (ALL)

for
Philadelphia Chromosome Negative,
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18 - 50

Code: NCT06785324

Recruiting

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

for
Recurrent Langerhans Cell Histiocytosis,
Location: Chicago IL, Peoria IL, Milwaukee WI, Kalamazoo MI,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 22

Code: NCT05828069

Phase2, Recruiting

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

for
Malignant Glioma
Location: Chicago IL, Peoria IL, Milwaukee WI, Madison WI,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 21

Code: NCT05099003

Phase1, Phase2, Recruiting

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

for
Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm,
Location: Chicago IL, Dyer IN, Urbana IL, Springfield IL,
Sponsor: BriaCell Therapeutics Corporation

Sex: All

Age: 18+

Code: NCT06072612

Phase3, Recruiting

A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs

for
Triple Negative Breast Cancer
Location: Chicago IL, New York NY, Aurora CO, Boston MA,
Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd.

Sex: All

Age: 18+

Code: NCT06908928

Phase1, Recruiting

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
Location: Chicago IL, Madison WI, Springfield IL, Grand Rapids MI,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06119581

Phase3, Recruiting

A Bionic Breast Project Using Neuroprosthesis to Reduce Chronic Pain After Mastectomy

for
Mastectomy, Breast, Chronic Pain
Location: Chicago IL
Sponsor: University of Chicago

Sex: Female

Age: 18+

Code: NCT06382272

Recruiting

Proteogenomic Monitoring and Assessment of Liver Transplant Recipients

for
Liver Transplant, Hepatitis C, Chronic Kidney Disease,
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT01644903

Recruiting

NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)

for
Duchenne Muscular Dystrophy, Exon 44, DMD
Location: Chicago IL, Cincinnati OH, London, Kansas City KS,
Sponsor: NS Pharma, Inc.

Sex: Male

Age: 4 - 14

Code: NCT05996003

Phase2, Recruiting

International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

for
Gaucher Disease, Cerebroside Lipidosis Syndrome,
Location: Aurora IL, Chicago IL, Milwaukee WI, Indianapolis IN,
Sponsor: Genzyme, a Sanofi Company

Sex: All

Age: 0+

Code: NCT00358943

Recruiting

A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

for
Cervical Squamous Cell Carcinoma,
Location: Chicago IL, Louisville KY, Fairfax VA, Hackensack NJ,
Sponsor: Alentis Therapeutics AG

Sex: All

Age: 18+

Code: NCT07169734

Phase1, Phase2, Recruiting

Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia

for
Acute Lymphoblastic Leukemia, T-cell Lymphoblastic Lymphoma
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 15+

Code: NCT06446661

Recruiting